COO and CFO
Thu, Apr 23, 2026
Apr 23
returned securities to the issuer in DAWN
312,025 shares @ $0.00
Decreased holdings by -100.00%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology